<DOC>
	<DOC>NCT00240604</DOC>
	<brief_summary>Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.</brief_summary>
	<brief_title>Prevention of Corticosteroid-induced Glucose Intolerance</brief_title>
	<detailed_description>Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.</detailed_description>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>corticosteroid treatment congestive heart failure pedal edema</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>corticosteroid treatment</keyword>
	<keyword>inflammatory diseases</keyword>
</DOC>